PAR-25-051-Full-Announcement.html

This document is a full announcement for the federal grant opportunity titled "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)".

The grant opportunity is offered by the Department of Health and Human Services' National Institutes of Health. It is assigned to several NIH grant programs including Mental Health Research Grants, Alcohol Research Programs, Drug Use and Addiction Research Programs, and others. The grant aims to support neuroscience investigators in advancing their small molecule drug discovery and development projects into the clinic. Eligible applicant types include state/local governments, nonprofits, universities, small businesses, and tribal organizations. Successful applicants will collaborate with NIH-funded consultants and access NIH contract research organizations for various drug development activities. Projects can enter at either the Discovery or Development stage. Applicants retain IP rights for drug candidates developed through the program.